Comments
Natco Pharma Ltd has announced the completion of a pre-approval inspection from the United States Food and Drug Administration (USFDA) for its formulation facility in Kothur Village, near Hyderabad. The inspection was conducted from March 2 to 6.
At the end of the inspection, the facility received a single observation related to equipment qualification of a co-mill used in the process that had operating speed slightly outside the qualification range. The company believes that this is a minor observation and can be addressed soon.
The company will provide justification and corrective action plan within the next 15 working days to address this observation, Natco informed in a statement.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.